Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Lymphadenopathy, Muscular weakness, Pain in extremity, Red blood cell sedimentation rate normal
Clinical narrative: swollen lymph node under the shot arm; feel pain and weakness in her hands/pain has now spread to her feet; feel pain and weakness in her hands; inability to drive her car as she was unable to grasp the steering wheel; pain has now spread to her knees and feet; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 38 year-old female patient received bnt162b2 (BNT162B2), administration date May2021 (Batch/Lot number: unknown) at the age of 38 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Single), administration date: May2021, when the patient was 38 years old, for Covid-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 2021, outcome "recovered" (2021), described as "swollen lymph node under the shot arm"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "feel pain and weakness in her hands/pain has now spread to her feet"; MUSCULAR WEAKNESS (non-serious) with onset 2021, outcome "unknown", described as "feel pain and weakness in her hands"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 2021, outcome "unknown", described as "inability to drive her car as she was unable to grasp the steering wheel"; ARTHRALGIA (non-serious) with onset 2021, outcome "unknown", described as "pain has now spread to her knees and feet". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of lymphadenopathy, pain in extremity, muscular weakness, loss of personal independence in daily activities, arthralgia.  Additional information: The reporter mentioned that the patient (her daughter) age 38 and in previously good health before receiving vaccine. Twenty-four hours after receiving the second dose she reported a swollen lymph node under the shot arm. Five days later she began to feel pain and weakness in her hands. The swollen lymph node returned to normal shortly thereafter. Her daughter's pain and weakness in her hands has slowly increased over the days and months. Today she reported an inability to drive her car as she was unable to grasp the steering wheel. The pain had now spread to her knees and feet. She was currently under the care at a rheumatologist. Her blood work had all been negative or insignificant for Rheumatoid Factor, Lyme Disease, Parvo, Celieac Panel, Serum protein electrophoresis, CRP, ESR, ANA, etc. He had her on a regimen of steroids and hydroxychloroquine. The patient's pain level, especially in the morning, was nearing a nine out of ten. She had never had COVID. Reporter queried if there was any treatment for resulted events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.